American Century Companies has boosted its stake in Biohaven (BHVN) by 9.5% during Q4, ETF Daily News reports, citing a recent SEC filing. The firm owned 558,761 shares of Biohaven after purchasing an additional 48,286 shares during the period, the report notes.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BHVN:
- Biohaven falls -10.9%
- Immunovant data positive for Biohaven, says Deutsche Bank
- Positive Outlook for Biohaven Ltd. Amid Promising Developments and FDA Priority Review
- Biotech Alert: Searches spiking for these stocks today
- Optimistic Buy Rating for Biohaven Ltd. Amid Promising Drug Developments and Strategic Pipeline Advancements